Abbvie Contract MFG

Proprietary Hot Melt Extrusion (HME) technology has become a cornerstone in drug manufacturing, revolutionizing the formulation and production of pharmaceutical products. This advanced process combines heat and pressure to transform raw components into a homogeneous, uniform product. The unique aspect of proprietary HME lies in its diverse formulations and techniques, which are often closely guarded by pharmaceutical companies to maintain a competitive advantage. One of the standout features of proprietary HME is its flexibility. The process can integrate a wide range of poorly soluble drugs and various pharmaceutical ingredients into a single dosage form. This versatility addresses formulation challenges that traditional methods may struggle with, ultimately enhancing drug bioavailability and efficacy. Moreover, HME’s adaptability allows for the development of customized formulations tailored to specific patient needs, fostering innovation and differentiation in the pharmaceutical ma...

Hot Melt Extrusion (HME) has become a game-changing technology in pharmaceutical manufacturing. By using heat and pressure to blend active pharmaceutical ingredients (APIs) with polymers and other excipients, HME enables the creation of stable and innovative drug delivery systems. While standard HME processes are effective, proprietary HME technologies take the benefits to the next level, offering unparalleled flexibility, efficiency, and market advantage. What is Hot Melt Extrusion? HME services are a continuous manufacturing process where raw materials are combined, melted, and extruded into a final product. It is widely used in the development of solid dispersions to enhance the solubility and bioavailability of poorly water-soluble drugs. HME can also be used to create various dosage forms, such as tablets, films, and implants. Why Choose Proprietary HME? Tailored Solutions for Complex APIs: Proprietary HME allows for customization of the process and materials to suit the unique ...